Amphastar Pharm Shows Rising Relative Strength; Still Shy Of Key Threshold
Learn how to manage stock market exposure by using IBD's RS Rating to identify market leaders with scores from 1 to 99. Evaluate Amphastar Pharm's potential for growth by analyzing its RS Rating, earnings, and revenue trends.